Dana Investment Advisors, Inc.
Position in DNLI — Denali Therapeutics Inc.
CIK 1427514
BROOKFIELD, WI
Position in DNLI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,542,454
+$545,552 QoQ
Shares Held
59,971
+15.5% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#105
of 290 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Dana Investment Advisors, Inc. holds $43,128,971 across 12 Biotechnology names. DNLI ranks #10 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
57,520 | $18,181,496 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
22,850 | $5,592,994 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,719 | $4,813,105 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
42,012 | $2,308,139 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
57,854 | $2,256,884 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,677 | $1,974,365 | |
| 7 | ZYME |
Zymeworks Inc.
|
71,660 | $1,873,192 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
23,272 | $1,845,236 |
All Filings in DNLI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,542,454 | 59,971 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $996,902 | 51,922 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $835,108 | 50,582 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $736,396 | 50,716 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $497,498 | 35,561 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $437,147 | 32,155 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $699,074 | 34,302 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,015,238 | 34,852 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $795,726 | 34,269 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $590,073 | 28,756 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $516,263 | 24,057 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $508,096 | 24,629 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $798,511 | 27,059 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $617,448 | 26,799 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $698,475 | 25,116 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $625,983 | 20,397 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $392,890 | 13,350 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $363,392 | 11,296 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $429,854 | 9,638 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $469,790 | 9,312 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||